دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19
Igor H. Murai, PhD1; Alan L. Fernandes, PhD1; Lucas P. Sales, MSc1; Ana J. Pinto, BSc2; Karla F. Goessler, PhD2; Camila S. C. Duran, MD1; Carla B. R. Silva, MD1; André S. Franco, MD1; Marina B. Macedo, MD, MSc1; Henrique H. H. Dalmolin, MD1; Janaina Baggio, MD1; Guilherme G. M. Balbi, MD1; Bruna Z. Reis, PhD1; Leila Antonangelo, MD, PhD3; Valeria F. Caparbo, PhD1; Bruno Gualano, PhD2,4; Rosa M. R. Pereira, MD, PhD1
doi : 10.1001/jama.2020.26848
JAMA. 2021;325(11):1053-1060
Importance The efficacy of vitamin D3 supplementation in coronavirus disease 2019 (COVID-19) remains unclear.
Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation
Christine M. Albert, MD, MPH1,2; Nancy R. Cook, ScD2,3; Julie Pester, BA2; M. Vinayaga Moorthy, PhD2; Claire Ridge, MPH2; Jacqueline S. Danik, MD, DrPH4; Baris Gencer, MD2; Hasan K. Siddiqi, MD, MSCR2,5; Chee Ng, MD4; Heike Gibson, PhD2; Samia Mora, MD, MHS2,5; Julie E. Buring, ScD2,3; JoAnn E. Manson, MD, DrPH2,3
doi : 10.1001/jama.2021.1489
JAMA. 2021;325(11):1061-1073
Importance Atrial fibrillation (AF) is the most common heart rhythm disturbance, continues to increase in incidence, and results in significant morbidity and mortality. The marine omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and vitamin D have been reported to have both benefits and risks with respect to incident AF, but large-scale, long-term randomized trial data are lacking.
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
Leora R. Feldstein, PhD1,2; Mark W. Tenforde, MD1; Kevin G. Friedman, MD3; Margaret Newhams, MPH4; Erica Billig Rose, PhD1,2; Heda Dapul, MD5; Vijaya L. Soma, MD6; Aline B. Maddux, MD7; Peter M. Mourani, MD7; Cindy Bowens, MD8; Mia Maamari, MD8; Mark W. Hall, MD9; Becky J. Riggs, MD10; John S. Giuliano Jr, MD11; Aalok R. Singh, MD12; Simon Li, MD13; Michele Kong, MD14; Jennifer E. Schuster, MD15; Gwenn E. McLaughlin, MD16; Stephanie P. Schwartz, MD17; Tracie C. Walker, MD17; Laura L. Loftis, MD18; Charlotte V. Hobbs, MD19; Natasha B. Halasa, MD20; Sule Doymaz, MD21; Christopher J. Babbitt, MD22; Janet R. Hume, MD23; Shira J. Gertz, MD24; Katherine Irby, MD25; Katharine N. Clouser, MD26; Natalie Z. Cvijanovich, MD27; Tamara T. Bradford, MD28; Lincoln S. Smith, MD29; Sabrina M. Heidemann, MD30; Sheemon P. Zackai, MD31; Kari Wellnitz, MD32; Ryan A. Nofziger, MD33; Steven M. Horwitz, MD34; Ryan W. Carroll, MD35; Courtney M. Rowan, MD36; Keiko M. Tarquinio, MD37; Elizabeth H. Mack, MD38; Julie C. Fitzgerald, MD39; Bria M. Coates, MD40; Ashley M. Jackson, MPH1; Cameron C. Young4; Mary Beth F. Son, MD41; Manish M. Patel, MD1,2; Jane W. Newburger, MD3; Adrienne G. Randolph, MD4,42; for the Overcoming COVID-19 Investigators
doi : 10.1001/jama.2021.2091
JAMA. 2021;325(11):1074-1087.
Importance Refinement of criteria for multisystem inflammatory syndrome in children (MIS-C) may inform efforts to improve health outcomes.
Telehealth Use Among Safety-Net Organizations in California During the COVID-19 Pandemic
Lori Uscher-Pines, PhD, MSc1; Jessica Sousa, MSW, MPH1; Maggie Jones, MPH2; Christopher Whaley, PhD1; Christopher Perrone, MPP3; Colleen McCullough, MPA1; Allison J. Ober, PhD1
doi : 10.1001/jama.2021.0282
JAMA. 2021;325(11):1106-1107
Alcohol-Related Deaths in Poland During a Period of Weakening Alcohol Control Measures
Witold A. Zato?ski, MD, PhD1; Mateusz Zato?ski, PhD2; Kinga Janik-Koncewicz, MSc1; Andrzej Wojty?a, MD, PhD3
doi : 10.1001/jama.2020.25879
JAMA. 2021;325(11):1108-1109
Improving Health Among Rural Residents in the US
Katy Backes Kozhimannil, PhD, MPA1; Carrie Henning-Smith, PhD, MPH, MSW1
doi : 10.1001/jama.2020.26372
JAMA. 2021;325(11):1033-1034
Improving the Health of the American Indian and Alaska Native Population
Thomas D. Sequist, MD, MPH1,2
doi : 10.1001/jama.2021.0521
JAMA. 2021;325(11):1035-1036
SARS-CoV-2 Variants of Concern in the United States—Challenges and Opportunities
Rochelle P. Walensky, MD, MPH1; Henry T. Walke, MD, MPH1; Anthony S. Fauci, MD2
doi : 10.1001/jama.2021.2294
JAMA. 2021;325(11):1037-1038
COVID-19 Vaccination in Pregnant and Lactating Women
Emily H. Adhikari, MD1,2; Catherine Y. Spong, MD1,2
doi : 10.1001/jama.2021.1658
JAMA. 2021;325(11):1039-1040
Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines
Diana W. Bianchi, MD1; Lisa Kaeser, JD1; Alison N. Cernich, PhD1
doi : 10.1001/jama.2021.1865
JAMA. 2021;325(11):1041-1042
New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes
Dhaval Kolte, MD, PhD1; Peter Libby, MD2; Ik-Kyung Jang, MD, PhD1,3
doi : 10.1001/jama.2021.0069
JAMA. 2021;325(11):1043-1044
Somebody’s Sunshine
Emily Pinto Taylor, MD1
doi : 10.1001/jama.2021.1549
JAMA. 2021;325(11):1045-1046
Vitamin D3 to Treat COVID-19: Different Disease, Same Answer
David E. Leaf, MD, MMSc1; Adit A. Ginde, MD, MPH2
doi : 10.1001/jama.2020.26850
JAMA. 2021;325(11):1047-1048
The Reporting of Race and Ethnicity in Medical and Science Journals
Annette Flanagin, RN, MA1; Tracy Frey, BA2; Stacy L. Christiansen, MA3; Howard Bauchner, MD4
doi : 10.1001/jama.2021.2104
JAMA. 2021;325(11):1049-1052
Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke
Scott J. Mendelson, PhD, MD1; Shyam Prabhakaran, MD, MS1,2
doi : 10.1001/jama.2020.26867
JAMA. 2021;325(11):1088-1098
Importance Stroke is the fifth leading cause of death and a leading cause of disability in the United States, affecting nearly 800?000 individuals annually.
Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021
Sonja A. Rasmussen, MD, MS1,2; Denise J. Jamieson, MD, MPH3
doi : 10.1001/jama.2021.1683
JAMA. 2021;325(11):1099-1100
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021
Tom T. Shimabukuro, MD, MPH, MBA1; Matthew Cole, MPH2; John R. Su, MD, PhD, MPH1
doi : 10.1001/jama.2021.1967
JAMA. 2021;325(11):1101-1102
Pruritic Rash and Diarrhea
Hiroyuki Yano, MD1; Mitsuyo Kinjo, MD, MPH1
doi : 10.1001/jama.2020.24066
JAMA. 2021;325(11):1103-1104
Omega-3 Fatty Acids and Atrial Fibrillation
Gregory Curfman, MD1
doi : 10.1001/jama.2021.2909
JAMA. 2021;325(11):1063
Pregnant People’s Paradox—Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications
Rita Rubin, MA
doi : 10.1001/jama.2021.2264
JAMA. 2021;325(11):1027-1028
CAR-T Therapy Is Approved for Non-Hodgkin Lymphoma
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2021.3004
JAMA. 2021;325(11):1032
Device Uses Electrical Stimulation to Control Snoring
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2021.2622
JAMA. 2021;325(11):1032
Helping Manufacturers Navigate Novel Coronavirus Variants
Mary Chris Jaklevic, MSJ
doi : 10.1001/jama.2021.3006
JAMA. 2021;325(11):1032
2020 Revealed How Poorly the US Was Prepared for COVID-19—and Future Pandemics
Gail R. Wilensky, PhD1
doi : 10.1001/jama.2021.1046
JAMA. 2021;325(11):1029-1030
Saving Tens of Thousands of Lives by Cutting Air Pollution
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.2292
JAMA. 2021;325(11):1031
Most Patients Hospitalized With COVID-19 Have Lasting Symptoms
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.2974
JAMA. 2021;325(11):1031
New WHO Guideline for Treating Chronic Pain in Children
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.2976
JAMA. 2021;325(11):1031
The Achievement of the Army Medical Department in the World War
doi : 10.1001/jama.2020.17846
JAMA. 2021;325(11):1115
Spontaneous Bacterial Peritonitis
Grace Zhang, BS1; Alison Jazwinski Faust, MD2
doi : 10.1001/jama.2020.10292
JAMA. 2021;325(11):1118
Algorithm to Evaluate Abnormal Liver Function Tests in Liver Transplant Patients
Tom Winter, MD1
doi : 10.1001/jama.2021.0162
JAMA. 2021;325(11):1109-1110
Algorithm to Evaluate Abnormal Liver Function Tests in Liver Transplant Patients—Reply
Edward Wolfgang Lee, MD, PhD1; Sammy Saab, MD, MPH2; Fady M. Kaldas, MD2
doi : 10.1001/jama.2021.0165
JAMA. 2021;325(11):1110
Evaluation of a Strength-Training Program on Clinical Outcomes in Older Adults
Johannes Burtscher, PhD1; Grégoire P. Millet, PhD1; Martin Burtscher, PhD, MD2
doi : 10.1001/jama.2021.0337
JAMA. 2021;325(11):1110-1111
Evaluation of a Strength-Training Program on Clinical Outcomes in Older Adults
Cory W. Baumann, PhD1; Todd M. Manini, PhD2; Brian C. Clark, PhD1
doi : 10.1001/jama.2021.0298
JAMA. 2021;325(11):1111
Evaluation of a Strength-Training Program on Clinical Outcomes in Older Adults
Claudio R. Nigg, PhD1; Barbara Resnick, PhD, RN, CRNP2; David X. Marquez, PhD3
doi : 10.1001/jama.2021.0301
JAMA. 2021;325(11):1111-1112
Evaluation of a Strength-Training Program on Clinical Outcomes in Older Adults—Reply
Heike A. Bischoff-Ferrari, MD, DrPH1; Robert Theiler, MD1; Caroline de Godoi Rezende Costa Molino, PhD2
doi : 10.1001/jama.2021.0304
JAMA. 2021;325(11):1112-1113
